Delcath Systems, Inc. (DCTH) Investor Relations Documents

Delcath Systems, Inc. (DCTH) investor relations documents from the company's IR site: 2 presentations, 14 press releases; latest deck 2026-08-06. Read in-app with summaries. First-party data.

Investor Presentation — Delcath Systems (NASDAQ: DCTH) is a commercial-stage oncology company whose primary asset is the FDA-approved HEPZATO KIT for metastatic uveal melanoma.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-06PresentationInvestor Presentation
2026-08-06Press releaseDelcath Systems Reports Second Quarter 2026 Results and Business Highlights
2026-07-28Press releaseDelcath Systems to Participate at the Canaccord Genuity 46th Annual Growth Conference
2026-07-23Press releaseDelcath Systems to Host Second Quarter 2026 Earnings Call
2026-07-16Press releaseDelcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-07-09Press releaseDelcath Systems Announces First Patient Dosed in Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Breast
2026-05-26Press releaseDelcath Systems Announces Two ASCO 2026 Investigator Initiated Trials-in-Progress Abstracts
2026-05-15Press releaseDelcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-05-12Press releaseDelcath Systems to Participate at the H.C. Wainwright 4th Annual BioConnect Investor Conference
2026-05-07Press releaseDelcath Systems Reports First Quarter 2026 Results and Business Highlights
2026-05-07Press releaseDelcath Systems Announces Presentation of New Data on Percutaneous Hepatic Perfusion with Melphalan in Liver-Dominant Me
2026-04-06Press releaseDelcath Systems, Inc. Announces Inclusion of CHEMOSAT Hepatic Delivery System for Melphalan as a Recommended Liver-Direc
2026-04-01Press releaseDelcath Systems to Participate at the Society of Interventional Radiology 2026 Meeting
2026-03-03Press releaseDelcath Systems Announces Publication of CHOPIN Clinical Trial Results in The Lancet Oncology
2026-01-27Press releaseDelcath Systems to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conferen
2021-11-05Investor meetingDelcath Systems to Hold Investor Update on Focus Trial Data and Future Development Plans on December 2, 2021

DCTH overview · DCTH earnings · DCTH financials · DCTH KPIs · DCTH ownership · DCTH peers · DCTH filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.